Naveris Announces Abstract Accepted for Presentation at the 2022 American Society for Clinical Oncology Meeting
In full transparency, the following is a press release submitted to SOURCE media through its business wire service. *** NATICK
Read more
Naveris
Natick Company’s Head & Neck Cancer Recurrence Detection Study Selected For Presentation
If full transparency, the following press release was submitted to SOURCE media via its business wire service. *** NATICK –
Read more
Natick Company Raises $19 Million To Advance Early Detection of HPV & Other Viral Cancers
The following is a press release submitted to SOURCE media through its business wire service. *** NATICK – Naveris, a
Read more